S. Korean gov't sends official opinion paper to U.S. over pharma tariff measures

And amid Trump's tariff threats on the pharmaceutical industry, the South Korean government is attempting to boost its cooperation with the U.S.

The Health Ministry announced on Tuesday that it had sent an official opinion paper to the U.S. on Sunday which stated that the import of Korean pharmaceuticals contributes to the stability of U.S. supply chains and improved patient accessibility to drugs.

It especially sought to highlight that the tariff measures are unnecessary as Korean pharmaceuticals do not pose a threat to U.S. national security.